IPCA Laboratories Limited
Kotak Offshore has dropped off IPCA Laboratories Limited's latest shareholder list after previously holding a 1.14 percent stake. This shift indicates Kotak Offshore either completely exited its position or trimmed the holding below the 1 percent reporting threshold.
A pharmaceutical manufacturer and marketer, Ipca Labs produces a wide range of medicines across therapeutic areas including antimalarials, anti-infectives, gastrointestinal treatments, and gynecological formulations. The company operates manufacturing facilities across India and exports its products to international markets. Its distinctive strength lies in its expertise in complex drug formulations, established distribution networks across Indian states, and a focus on affordable healthcare solutions for domestic and global markets.
India FPI activity attributed to Kotak Mahindra group affiliates and offshore funds investing in listed Indian equities.